Literature DB >> 14678527

Seborrheic dermatitis.

A K Gupta1, R Bluhm.   

Abstract

UNLABELLED: Seborrheic dermatitis is a common inflammation of the skin, occurring most often on the face, scalp and chest. It is closely related to infantile seborrheic dermatitis, or diaper rash. Seborrheic dermatitis is particularly common in patients with Parkinson's disease or with HIV/AIDS. The recent resurgence of interest in Malassezia yeasts has revived the old hypothesis that seborrheic dermatitis is caused by an altered relationship between these skin commensals and the host. Moreover, the success of antifungal medications in treating seborrheic dermatitis provides new evidence for this view. LEARNING
OBJECTIVE: Upon completing this paper, the reader should be aware of the clinical presentation of seborrheic dermatitis and which populations are at particular risk of developing this disorder. In addition, s/he will be aware of the role of Malassezia yeasts in seborrheic dermatitis and the way in which knowledge of the importance of these yeasts has altered the treatment of this disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14678527     DOI: 10.1111/j.1468-3083.2004.00693.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  29 in total

Review 1.  [Psoriasis and eczema on the scalp].

Authors:  D Wilsmann-Theis; T Bieber
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

2.  Seborrheic dermatitis.

Authors:  Thomas Berk; Noah Scheinfeld
Journal:  P T       Date:  2010-06

3.  In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains.

Authors:  Christine Roques; Sabine Brousse; Cédric Panizzutti
Journal:  Mycopathologia       Date:  2006-12       Impact factor: 2.574

Review 4.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

5.  Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.

Authors:  Victor Kenyon; Ganesha Rai; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Steven Perry; Netra Joshi; James M Bougie; William Leister; David A Taylor-Fishwick; Jerry L Nadler; Michael Holinstat; Anton Simeonov; David J Maloney; Theodore R Holman
Journal:  J Med Chem       Date:  2011-07-08       Impact factor: 7.446

6.  Pathology of the ear.

Authors:  Ida Orengo; Kerri Robbins; Amanda Marsch
Journal:  Semin Plast Surg       Date:  2011-11       Impact factor: 2.314

Review 7.  Bitemporal Scalp Hair Loss: Differential Diagnosis of Nonscarring and Scarring Conditions.

Authors:  Brianna De Souza; Andrea Tovar-Garza; Laura N Uwakwe; Amy McMichael
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

8.  Evaluation of a Topical Anti-inflammatory/Antifungal Combination Cream in Mild-to-moderate Facial Seborrheic Dermatitis: An Intra-subject Controlled Trial Examining Treated vs. Untreated Skin Utilizing Clinical Features and Erythema-directed Digital Photography.

Authors:  Federica Dall'Oglio; Aurora Tedeschi; Vincenzo Guardabasso; Giuseppe Micali
Journal:  J Clin Aesthet Dermatol       Date:  2015-09

Review 9.  [Frequent and rare dermatological diseases in HIV patients].

Authors:  U R Hengge; R Mota; A Marini
Journal:  Hautarzt       Date:  2006-11       Impact factor: 0.751

10.  Noncorticosteroid Combination Shampoo versus 1% Ketoconazole Shampoo for the Management of Mild-to-Moderate Seborrheic Dermatitis of the Scalp: Results from a Randomized, Investigator-Single-Blind Trial Using Clinical and Trichoscopic Evaluation.

Authors:  Federica Dall'Oglio; Francesco Lacarrubba; Anna Elisa Verzì; Giuseppe Micali
Journal:  Skin Appendage Disord       Date:  2015-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.